Steven Schechter, MD
Colon & Rectal Surgery · Providence, RINPI 1740241876
Payments from drug & device makers
Across 67 payments — averaging $1213.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$44K
- Cook Research Incorporated$36K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$500
- MDD US Operations, LLC$337
- Medtronic$178
- Pacira Pharmaceuticals Incorporated$141
- plus $170 from 6 others
What the payments were for
- Consulting fees$7102%
- Speaking & faculty fees$43,45496%
- Food & beverage$9922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 16 | $43,831 |
| Cook Research Incorporated | 3 | $36,170 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $500 |
| MDD US Operations, LLC | 36 | $337 |
| Medtronic | 3 | $178 |
| Pacira Pharmaceuticals Incorporated | 2 | $141 |
| Novartis | 1 | $62 |
| Genentech USA, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Pfizer | 1 | $19 |
| TG Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIFAXAN$500
- EXPAREL$122
- Sonicision$114
How this compares
Too few colon & rectal surgery providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 11 | $1,710 |
| Ondansetron Hcl | 22 | $119 |
| Neomycin Sulfate | 17 | $99 |
| Oxycodone Hcl | 25 | $94 |
| Metronidazole | 16 | $19 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Providence
- Adam KlipfelProvidence$375K
- Leslie RothProvidence$9K
- Matthew VreesProvidence$8K
- Rebecca GologorskyProvidence$1K
- Thomas CataldoProvidence$533
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.